Cyclosporine A (CyA) is known to affect the local release of endotheli
al-derived relaxing factor (EDRF). However, evidence that CyA could sp
ecifically alter endothelial signal transduction is not well understoo
d. Experiments were designed to assess dose-dependent effect of CyA on
vascular reactivity-specificity of the rat thoracic aorta. Three grou
ps of rats (n = 10) were treated for 4 weeks with oral CyA 15 mg/kg/da
y (Gr 1), CyA 30 mg/kg/day (Gr 2), and olive oil (Gr 3), the CyA vehic
le. At the end of the period, animals were euthanized and the thoracic
aorta harvested for isometric assessment of endothelial and smooth mu
scle function in organ chambers. Maximal endothelial-dependent relaxat
ion (Rmax) to acetylcholine dose-response was similarly affected in ra
ts treated with CyA [Rmax (%): Gr 1: 33 +/- 8, Gr 2: 28 +/- 2, Gr 3: 5
1 +/- 7, *p<0.05]. At the opposite, response to adenosine diphosphate
[Rmax (%): Gr 1: 11+/-2, Gr 2. 24 +/- 3, Gr 3: 7 +/- 2, *p<0.01] and
histamine [dose-response CE(50) (log M): Gr 1: +/- 12 +/- 0.05, Gr 2:
+/- 5.45 +/- 0.05, Gr 3: -4.85 +/- 0.08, *p<0.05] were significantly
enhanced in animals exposed to 30 mg/kg/day. Endothelium-independent
relaxation to sodium nitroprusside (SNP) was comparable in all groups
and dose-response to depolarizing (KCl) and non-depolarizing (norepine
phrine) contractile agents were not affected either. These experiments
suggest that CyA does not affect second messenger (cyclic-GMP) activa
tion by an EDRF analogue (SNP) whereas signal transduction coupled to
muscarinic, purinergic, and histaminergic receptors are either inhibit
ed or enhanced by CyA in dose-dependent manner in the rat aortic model
.